China Money Network
Login
Join

Capital Group Private Markets Leads $150M Round In China’s Innovent Biologics

  • April 27, 2018 — 09:59 CST

This Data Is Locked!

This area is available only to Subscribers.

Capital Group Private Markets, a unit of U.S. investment firm Capital Group Companies, has led a US$150 million round in Chinese biotech firm Innovent Biologics,... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: